Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Farmak is a leading Ukrainian pharmaceutical company and a major international player with a presence in over 50 countries. Founded in 1925, the company specializes in the development, manufacturing, and marketing of high-quality generic and innovative medicines across various therapeutic areas, including cardiology, endocrinology, and ophthalmology. Farmak operates state-of-the-art manufacturing facilities that comply with international GMP standards and maintains a robust R&D center focused on complex generics and value-added medicines. The company has expanded its footprint through strategic acquisitions in Europe, such as Symphar in Poland, to strengthen its position in the EU market. It is the largest exporter of pharmaceutical products in Ukraine and continues to invest in biosimilars and advanced delivery systems.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Farmak International Holding.